National Research Program
The Leukaemia Foundation is committed to funding research innovations that drive rapid advancements in treatments, discover new diagnostics and novel therapies and enable Australian patients to access global clinical trials.
Our overarching aim is to fund high-impact research by concentrating our resources on projects with broad potential for all people living with blood cancer.
We have turned our attention to investment in innovation: in diagnosis, treatments and improving quality of life across the blood cancer spectrum.
The Leukaemia Foundation has been supporting Australian blood cancer research for over 20 years, committing $57.8 million to research since 2000.
Our National Research Program has the following research priorities:
- Understanding the biology of cancers
- Precision medicine – investing in new therapies that are tailor-made to treat each patient’s cancer
- New diagnostics
- Novel therapies and care options
- Psychosocial aspects of cancer
- Innovative clinical trials and/or incorporation of real-world data
- Prevention research including investigating blood cancer risk factors